This is of interest
"An FDA approval would also provide an opportunity to investigate different ways of structuring the Pharmaxis business and funding our drug development activities.”"
Could they go down the track of becoming a generic drug manufacturer. From memory PXS have FDA compliance at their premises.
- Forums
- ASX - By Stock
- SNT
- Ann: Change in substantial holding from Arix Bioscience
Ann: Change in substantial holding from Arix Bioscience, page-9
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.17M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.7¢ | $66.77K | 1.752M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 493 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 209403 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 493 | 0.039 |
3 | 202932 | 0.037 |
4 | 451544 | 0.036 |
6 | 1278604 | 0.035 |
1 | 200000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 209403 | 1 |
0.043 | 25000 | 1 |
0.045 | 45224 | 1 |
0.046 | 70076 | 2 |
0.047 | 33889 | 1 |
Last trade - 14.38pm 24/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online